| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 06/09/2011 | WO2011068821A1 Benzimidazole inhibitors of leukotriene production |
| 06/09/2011 | WO2011068211A1 2-pyridone compounds |
| 06/09/2011 | WO2011068171A1 Bicyclic nitrogen-containing saturated heterocyclic derivatives |
| 06/09/2011 | WO2011067560A1 Combination of droloxifene and clopidogrel |
| 06/09/2011 | WO2011067544A1 Diphenyl-pyrazolopyrdine derivatives, preparation thereof, and use thereof as nuclear receptor not modulators |
| 06/09/2011 | WO2011066783A1 Anti-cyr61 protein monoclonal antibodies and uses thereof |
| 06/09/2011 | WO2011066656A1 Compositions comprising igf1 agonists and uses thereof |
| 06/09/2011 | WO2011019867A3 Dietary supplements and methods for treating pain and inflammation |
| 06/09/2011 | US20110136917 Tetrahydro-isoalpha acid compositions and methods for weight management |
| 06/09/2011 | US20110136884 Selective subtype alpha 2 adrenergic agents and methods for use thereof |
| 06/09/2011 | US20110136879 Compound |
| 06/09/2011 | US20110136877 2-phenyl phenoxyacetic acids useful for treating inflammatory disorders |
| 06/09/2011 | US20110136876 Altering Pharmacokinetics of Pirfenidone Therapy |
| 06/09/2011 | US20110136869 Compounds Which Selectively Modulate The CB2 Receptor |
| 06/09/2011 | US20110136868 Agents for inhibiting osteoclastogenesis and/or osteoclast activation |
| 06/09/2011 | US20110136861 Quinolone inhibitors of lipoprotein-associated phospholipase a2 |
| 06/09/2011 | US20110136860 Compounds |
| 06/09/2011 | US20110136859 Compounds |
| 06/09/2011 | US20110136858 Preferred Combination Therapy |
| 06/09/2011 | US20110136857 Pyrrole[2,3-b]pyridine derivatives active as kinase inhibitors |
| 06/09/2011 | US20110136856 Novel imidazo[1,5-a]pyridine derivatives, method for preparing same and pharmaceutical compositions containing same |
| 06/09/2011 | US20110136835 Combination formulations of tranilast and allopurinol and methods related thereto |
| 06/09/2011 | US20110136830 Chromenone derivatives |
| 06/09/2011 | US20110136828 Substituted n-oxide pyrazine derivatives |
| 06/09/2011 | US20110136820 Heterocyclic Compounds as CCR2 Antagonists |
| 06/09/2011 | US20110136807 Bicyclic compositions and methods for modulating a kinase cascade |
| 06/09/2011 | US20110136802 Ship1 modulators and methods related thereto |
| 06/09/2011 | US20110136789 C-met protein kinase inhibitors |
| 06/09/2011 | US20110136780 Dihydropyrrolonaphtyridinone compounds as inhibitors of jak |
| 06/09/2011 | US20110136778 Nitrogen-containing spirocyclic compounds and pharmaceutical uses thereof |
| 06/09/2011 | US20110136768 Imatinib mesylate for the treatment of nephrogenic systemic fibrosis |
| 06/09/2011 | US20110136765 Pyrrolo[2,3-D]Pyrimidine Compounds |
| 06/09/2011 | US20110136760 Kinase Inhibitors Useful for the Treatment of Myleoproliferative Diseases and other Proliferative Diseases |
| 06/09/2011 | US20110136741 Dicarba-analogues of octreotide |
| 06/09/2011 | US20110136733 Analogues of glucose-dependent insulinotropic polypeptide |
| 06/09/2011 | US20110136728 Methods of increasing bone formation using leptin-related peptides |
| 06/09/2011 | US20110136725 Analogues of glucose-dependent insulinotropic polypeptide (gip) modified at n-terminal |
| 06/09/2011 | US20110136724 Analogues of glucose-dependent insulinotropic polypeptide |
| 06/09/2011 | US20110135747 Homeopathic therapeutic method |
| 06/09/2011 | US20110135721 Preparations with rosehip extracts, and method of producing rosehip extracts |
| 06/09/2011 | US20110135707 Polyhydroxyalkanoates for in vivo applications |
| 06/09/2011 | US20110135678 Tolerizing agents |
| 06/09/2011 | US20110135652 Novel Use of Idbf |
| 06/09/2011 | US20110135632 Methods for the modulation of angiogenesis |
| 06/09/2011 | US20110135624 Therapeutic composition for autoimmune conditions |
| 06/09/2011 | US20110135594 Oxindolyl inhibitor compounds |
| 06/09/2011 | CA2782727A1 2-pyridone compounds |
| 06/09/2011 | CA2782704A1 Diphenyl-pyrazolopyrdine derivatives, preparation thereof, and use thereof as nuclear receptor not modulators |
| 06/08/2011 | EP2330197A2 Antagonistic selective binding agents of osteoprotegerin binding protein |
| 06/08/2011 | EP2330193A1 Improved antibody molecule |
| 06/08/2011 | EP2330192A1 Polypeptides and polynucleotides from coagulase-negative staphylococci |
| 06/08/2011 | EP2330187A2 Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic diseases |
| 06/08/2011 | EP2329847A2 Use of an antibody or an immunotoxin that selectively binds to CD123 to impair hematologic cancer progenitor cells |
| 06/08/2011 | EP2329832A1 Protein formulation |
| 06/08/2011 | EP2329828A1 Tetracyclines for the treatment of ischaemia |
| 06/08/2011 | EP2329826A1 Tetracyclines for the treatment of multiple sclerosis |
| 06/08/2011 | EP2329723A1 Fruit and/or vegetable derived composition |
| 06/08/2011 | EP2328932A1 Anti-cd5 antibodies |
| 06/08/2011 | EP2328879A2 Compounds, compositions and methods of using same for modulating uric acid levels |
| 06/08/2011 | EP2328596A2 Bone augmentation utilizing muscle-derived progenitor compositions in biocompatible matrix, and treatments thereof |
| 06/08/2011 | EP1771200B1 Physiologically-active composition based on collagen |
| 06/08/2011 | EP1757610B1 Condensed pyrimidine derivative and xanthine oxidase inhibitor |
| 06/08/2011 | EP1538927B1 Fruit and/or vegetable derived composition |
| 06/08/2011 | EP1434579B1 Imidazole derivatives as antiinflammatory agents |
| 06/08/2011 | EP1431293B1 Water-soluble phenylpyridazine derivatives and drugs containing the same |
| 06/08/2011 | EP1427427B1 Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect |
| 06/08/2011 | EP1259259B1 Mucosal adjuvant formulation |
| 06/08/2011 | CN1958050B Composition of Chinese traditional medicine for treating rickets, and preparation method |
| 06/08/2011 | CN1887312B Chinese medicine composition and its preparation process and effective ingredient detection method |
| 06/08/2011 | CN102089300A Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| 06/08/2011 | CN102089281A Novel indole derivative having carbamoyl group, ureide group and substituted oxy group |
| 06/08/2011 | CN102089277A Cyclic amine-1-carboxylic acid ester derivative and pharmaceutical composition containing the same |
| 06/08/2011 | CN102089010A Dicabba-analogues of octreotide |
| 06/08/2011 | CN102089008A Manufacturing method of collagen gel composition for bone regeneration |
| 06/08/2011 | CN102088975A Pharmaceutical compositions based on kinin B2 receptor antagonists and corticosteroids, and their use |
| 06/08/2011 | CN102086195A Dasatinib polymorphic substance as well as preparation method and medicinal composition thereof |
| 06/08/2011 | CN102085367A Application of optimized TACI (Transmembrane Activator and CAML Interactor)-Fc fusion protein in preparation of medicaments for treating rheumatoid arthritis |
| 06/08/2011 | CN102085356A Composition for increasing bone mineral density and preparation method thereof |
| 06/08/2011 | CN102085350A Medicament for treating arthritis and preparation method thereof |
| 06/08/2011 | CN102085339A Tibetan medicine for treating cervical spondylosis |
| 06/08/2011 | CN102085331A Drug for treating gout |
| 06/08/2011 | CN102085315A Traditional Chinese medicine composition for treating acute and chronic osteomyelitis |
| 06/08/2011 | CN102085289A Traditional Chinese medicine for treating bone fracture |
| 06/08/2011 | CN102085285A Traditional Chinese medicine combined prescription for treating paraplegia and bone fracture sequelae |
| 06/08/2011 | CN102085265A Medicine for treating hyperosteogeny and preparation method thereof |
| 06/08/2011 | CN102085253A Compound green vitriol capsule |
| 06/08/2011 | CN102085224A Method for preparing nano-level notoginseng root powder |
| 06/08/2011 | CN102085199A Percutaneous absorption biological patch for treating rheumatoid arthritis and preparing method thereof |
| 06/08/2011 | CN102085182A Sinomenine hydrochloride slow-release injection and preparation method thereof |
| 06/08/2011 | CN101780257B Traditional Chinese medicine for treating rheumatoid arthritis |
| 06/08/2011 | CN101745026B Setting bone and promoting blood flow plaster for treating fractures and injuries and preparation method thereof |
| 06/08/2011 | CN101732450B Medicinal liquor for treating rheumatic arthritis |
| 06/08/2011 | CN101708160B Pamidronate disodium suspension injection |
| 06/08/2011 | CN101703654B Medicament patch for treating rheumatoid hyperostosis and preparation method thereof |
| 06/08/2011 | CN101693049B Sambucus chinensis extract and preparation method thereof |
| 06/08/2011 | CN101658519B Medicinal composition for treating hyperuricemia |
| 06/08/2011 | CN101647915B Medicinal liquor for treating lumbocrural pain and preparation method |
| 06/08/2011 | CN101647909B Externally-applied medicine for treating fracture |
| 06/08/2011 | CN101618189B Medicine for treating hyperosteogeny and preparation method thereof |
| 06/08/2011 | CN101607057B Externally applied Chinese medicament for treating osteopathy and various pains |